This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech medical breakthrough

Gut-Brain Pathway for Appetite Loss

Analysis based on 8 articles · First reported Mar 24, 2026 · Last updated Mar 25, 2026

Sentiment
60
Attention
4
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

This medical breakthrough by University of California, San Francisco could lead to new treatments for parasitic infections, irritable bowel syndrome, and food intolerances, potentially boosting the pharmaceutical and biotechnology sectors. The findings may also open new avenues for drug development targeting gut-brain communication pathways.

Biotechnology Pharmaceuticals Healthcare

Researchers at University of California, San Francisco, led by David Julius and Richard Li, with key contributions from Koki Tohara, have identified the molecular pathway that connects the gut immune system to the brain during parasitic infections, explaining the phenomenon of appetite loss. The study, published in Nature, reveals an unexpected communication system between two rare cell types in the gut: tuft cells and enterochromaffin (EC) cells. Tuft cells detect parasites and release acetylcholine, a chemical messenger, which then triggers EC cells to release serotonin. This serotonin activates vagal nerve fibers, sending signals to the brain that suppress appetite. The team also discovered that tuft cells release acetylcholine in two distinct phases, explaining why appetite loss is often delayed. This breakthrough has significant implications beyond parasitic infections, potentially offering new insights and treatment strategies for conditions like irritable bowel syndrome, food intolerances, and chronic visceral pain. The work was conducted in collaboration with Stuart Brierley and his lab at University of Adelaide and received funding from entities like United States — National Institutes of Health and Howard Hughes Medical Institute.

per
David Julius, co-senior author and Nobel Prize recipient, led the research at University of California, San Francisco that uncovered the molecular logic behind appetite loss during parasitic infections.
Importance 80.0 Sentiment 50.0
per
Koki Tohara, first author and postdoctoral researcher at University of California, San Francisco, conducted key experiments revealing tuft cells' acetylcholine release and its role in gut-brain communication.
Importance 70.0 Sentiment 50.0
per
Stuart Brierley and his lab group at University of Adelaide collaborated on the study, providing expertise in gut-brain signaling.
Importance 40.0 Sentiment 30.0
per
Importance 0.0 Sentiment 0.0
ngo
Importance 0.0 Sentiment 0.0
govactor
Importance 0.0 Sentiment 0.0
govactor
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.